Liby KT - Search Results

1

Retinoid X Receptor agonists as selective modulators of the immune system for the treatment of cancer.

Leal AS, Hung PY, Chowdhury AS, Liby KT. Leal AS, et al. Among authors: liby kt. Pharmacol Ther. 2023 Dec;252:108561. doi: 10.1016/j.pharmthera.2023.108561. Epub 2023 Nov 10. Pharmacol Ther. 2023. PMID: 37952906 Review.

2

The Novel RXR Agonist MSU-42011 Differentially Regulates Gene Expression in Mammary Tumors of MMTV-Neu Mice.

Reich LA, Leal AS, Ellsworth E, Liby KT. Reich LA, et al. Among authors: liby kt. Int J Mol Sci. 2023 Feb 21;24(5):4298. doi: 10.3390/ijms24054298. Int J Mol Sci. 2023. PMID: 36901727 Free PMC article.

3

The Triterpenoid CDDO-Methyl Ester Redirects Macrophage Polarization and Reduces Lung Tumor Burden in a Nrf2-Dependent Manner.

Moerland JA, Leal AS, Lockwood B, Demireva EY, Xie H, Krieger-Burke T, Liby KT. Moerland JA, et al. Among authors: liby kt. Antioxidants (Basel). 2023 Jan 3;12(1):116. doi: 10.3390/antiox12010116. Antioxidants (Basel). 2023. PMID: 36670978 Free PMC article.

4

Adipocyte-derived kynurenine stimulates malignant transformation of mammary epithelial cells through the aryl hydrocarbon receptor.

Diedrich JD, Gonzalez-Pons R, Medeiros HCD, Ensink E, Liby KT, Wellberg EA, Lunt SY, Bernard JJ. Diedrich JD, et al. Among authors: liby kt. Biochem Pharmacol. 2023 Oct;216:115763. doi: 10.1016/j.bcp.2023.115763. Epub 2023 Aug 23. Biochem Pharmacol. 2023. PMID: 37625554 Free PMC article.

5

Ocular injury progression and cornea histopathology from chloropicrin vapor exposure: Relevant clinical biomarkers in mice.

Ebenezar OO, Roney A, Goswami DG, Petrash JM, Sledge D, Komáromy AM, Liby KT, Tewari-Singh N. Ebenezar OO, et al. Among authors: liby kt. Exp Eye Res. 2023 May;230:109440. doi: 10.1016/j.exer.2023.109440. Epub 2023 Mar 17. Exp Eye Res. 2023. PMID: 36933694 Free article.

6

Exploring structural effects in a new class of NRF2 inhibitors.

Hou Z, Lockwood L, Zhang D, Occhiuto CJ, Mo L, Aldrich KE, Stoub HE, Gallo KA, Liby KT, Odom AL. Hou Z, et al. Among authors: liby kt. RSC Med Chem. 2022 Nov 16;14(1):74-84. doi: 10.1039/d2md00211f. eCollection 2023 Jan 25. RSC Med Chem. 2022. PMID: 36760735 Free PMC article.

7

KEAP1-Mutant Lung Cancers Weaken Anti-Tumor Immunity and Promote an M2-like Macrophage Phenotype.

Occhiuto CJ, Liby KT. Occhiuto CJ, et al. Among authors: liby kt. Int J Mol Sci. 2024 Mar 20;25(6):3510. doi: 10.3390/ijms25063510. Int J Mol Sci. 2024. PMID: 38542481 Free PMC article.

8

CDDO-Methyl Ester Inhibits BRAF Inhibitor Resistance and Remodels the Myeloid Compartment in BRAF-mutant Melanoma.

Torres GM, Jarnagin HC, Park C, Yang H, Kosarek NN, Bhandari R, Wang CY, Kolling FW, Whitfield ML, Turk MJ, Liby KT, Pioli PA. Torres GM, et al. Among authors: liby kt. bioRxiv [Preprint]. 2023 Aug 3:2023.08.01.551524. doi: 10.1101/2023.08.01.551524. bioRxiv. 2023. PMID: 37577680 Free PMC article. Preprint.

9

The Multi-Faceted Consequences of NRF2 Activation throughout Carcinogenesis.

Occhiuto CJ, Moerland JA, Leal AS, Gallo KA, Liby KT. Occhiuto CJ, et al. Among authors: liby kt. Mol Cells. 2023 Mar 31;46(3):176-186. doi: 10.14348/molcells.2023.2191. Epub 2023 Mar 22. Mol Cells. 2023. PMID: 36994476 Free PMC article. Review.

10

T Cells and CDDO-Me Attenuate Immunosuppressive Activation of Human Melanoma-Conditioned Macrophages.

Torres GM, Yang H, Park C, Spezza PA, Khatwani N, Bhandari R, Liby KT, Pioli PA. Torres GM, et al. Among authors: liby kt. Front Immunol. 2022 Feb 21;13:768753. doi: 10.3389/fimmu.2022.768753. eCollection 2022. Front Immunol. 2022. PMID: 35265066 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page